d3ccb10d90bfb04b2e1ead4e239a205e.jpg

Lighting giant OSRAM partners with AM company XTPL AM Industry

by Business

OSRAM Opto Semiconductors GmbH, one of the world’s biggest lighting equipment manufacturers, recently signed an agreement with Polish additive company XTPL S.A. Through the partnership, the companies will evaluate and validate parameters of XTPL’s 3D printing technology with the goal of implementing it into OSRAM’s production workflow. Specifically, OSRAM will explore using XTPL’s AM technology for the production of conductive interconnections for semiconductors in lighting devices.

6c015824f11a7a0cb8e27f65f9dd68a7.jpg

How medical device companies use AM for production today part 7: FabRx Medical

by Medical

Welcome to this month’s AM Focus: Medical. For the entire month of February, we are going to zoom in on the many possibilities that additive manufacturing is offering today to medical companies. In this article, we’re giving you a dose of FabRx, a pharmaceutical biotech company that develops pharmaceutical 3D printers and 3D printed tablets. Upcoming articles in the AM Focus will span innovative startups to giant multinational corporations, all of which are using AM in exciting ways. At the end of the month all the best content will be featured in 3dpbm’s Medical AM Focus 2020 eBook.

d450332dbdc21495721fe9b93cc456a9.jpg

Aspect Biosystems and the restorative capacity of bioprinting today Bioprinting

by Medical

The medical AM segment is multifaceted, consisting of 3D printed medical devices, anatomical models, prosthetics and more. Within the industry, bioprinting has carved out a prominent position, gaining interest across the board for its huge potentials in drug development and screening, therapeutic treatments and regenerative medicine, to name but a few. While much of the excitement surrounding bioprinting is focused on the future—what it could do—we want to look at what is happening now in the field that is exciting.

7230a472599c7b42e9ab0dc3a909782c.jpg

How medical companies use AM for production today, part 6: Zimmer Biomet and OPM Medical

by Medical

3dpbm’s AM Focus Medical continues to zoom in on the many possibilities that additive manufacturing is offering today to medical companies. We are now taking a closer look at Zimmer Biomet additive manufacturing, which includes the global distribution (exclusive in the US) of unique PEKK 3D printed implants by Oxford Performance Materials. In the previous episodes, we looked at other giants such as Stryker, J&J and Lima Corporate as well as interesting SMEs and startups. Upcoming episodes will continue to include many different types of players in this segment, ranging from highly innovative startups and SMEs to giant multinational corporations. At the end of the month, all the best content will be featured in 3dpbm’s Medical AM Focus 2020 eBook.

0d77c405c40d6a086433329716417fc9.jpg

Samuel, Son & Co. acquires 100% of Canadian AM company Burloak Technologies AM Industry

by Business

After acquiring a minority stake in additive company Burloak Technologies in 2017, Canada-based Samuel, Son & Co., Limited has announced the full acquisition of the company. Burloak, now fully owned by the Canadian metal manufacturing leader, specializes in AM and provides support to partners in the aerospace, automotive and industrial markets in the adoption and use of 3D printing.

77003c33f2fbd8cbc19b195847da372f.jpg

Biogelx and the role of bioinks in bioprinting today Bioprinting

by Medical

The medical AM segment is multifaceted, consisting of 3D printed medical devices, anatomical models, prosthetics and more. Within the industry, bioprinting has carved out a prominent position, gaining interest across the board for its huge potentials in drug development and screening, therapeutic treatments and regenerative medicine, to name but a few. While much of the excitement surrounding bioprinting is focused on the future—what it could do—we want to look at what is happening now in the field that is exciting.